Literature DB >> 30840895

Genetic Dissection of the Type III-A CRISPR-Cas System Csm Complex Reveals Roles of Individual Subunits.

Irmantas Mogila1, Migle Kazlauskiene1, Skaiste Valinskyte1, Giedre Tamulaitiene1, Gintautas Tamulaitis2, Virginijus Siksnys3.   

Abstract

The type III-A Csm complex of Streptococcus thermophilus (StCsm) provides immunity against invading nucleic acids through the coordinated action of three catalytic domains: RNase (Csm3), ssDNase (Cas10-HD), and cyclic oligoadenylates synthase (Cas10-Palm). The matured StCsm complex is composed of Cas10:Csm2:Csm3:Csm4:Csm5 subunits and 40-nt CRISPR RNA (crRNA). We have carried out gene disruptions for each subunit and isolated deletion complexes to reveal the role of individual subunits in complex assembly and function. We show that the Cas10-Csm4 subcomplex binds the 5'-handle of crRNA and triggers Csm3 oligomerization to form a padlock for crRNA binding. We demonstrate that Csm5 plays a key role in target RNA binding while Csm2 ensures RNA cleavage at multiple sites by Csm3. Finally, guided by deletion analysis, we engineered a minimal Csm complex containing only the Csm3, Csm4, and Cas10 subunits and crRNA and demonstrated that it retains all three catalytic activities, thus paving the way for practical applications.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR-Cas; Cas10; Cas6; Csm effector complex; Csm2; Csm3; Csm4; Csm5; minimal Csm complex

Mesh:

Substances:

Year:  2019        PMID: 30840895     DOI: 10.1016/j.celrep.2019.02.029

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  9 in total

1.  Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

Authors:  Jinzhong Lin; Mingxia Feng; Heping Zhang; Qunxin She
Journal:  Cell Discov       Date:  2020-05-12       Impact factor: 10.849

2.  Cmr3 regulates the suppression on cyclic oligoadenylate synthesis by tag complementarity in a Type III-B CRISPR-Cas system.

Authors:  Tong Guo; Fan Zheng; Zhifeng Zeng; Yang Yang; Qi Li; Qunxin She; Wenyuan Han
Journal:  RNA Biol       Date:  2019-07-17       Impact factor: 4.652

3.  Type III-A CRISPR systems as a versatile gene knockdown technology.

Authors:  Walter T Woodside; Nikita Vantsev; Ryan J Catchpole; Sandra C Garrett; Sara Olson; Brenton R Graveley; Michael P Terns
Journal:  RNA       Date:  2022-05-26       Impact factor: 5.636

Review 4.  Controlling and enhancing CRISPR systems.

Authors:  Haridha Shivram; Brady F Cress; Gavin J Knott; Jennifer A Doudna
Journal:  Nat Chem Biol       Date:  2020-12-16       Impact factor: 15.040

5.  Bio-Layer Interferometry Analysis of the Target Binding Activity of CRISPR-Cas Effector Complexes.

Authors:  Hanna Müller-Esparza; Manuel Osorio-Valeriano; Niklas Steube; Martin Thanbichler; Lennart Randau
Journal:  Front Mol Biosci       Date:  2020-05-27

Review 6.  The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies.

Authors:  Sydney Newsom; Hari Priya Parameshwaran; Lindsie Martin; Rakhi Rajan
Journal:  Front Cell Infect Microbiol       Date:  2021-01-28       Impact factor: 5.293

7.  Structural and biochemical characterization of in vivo assembled Lactococcus lactis CRISPR-Csm complex.

Authors:  Sagar Sridhara; Jay Rai; Charlisa Whyms; Hemant Goswami; Huan He; Walter Woodside; Michael P Terns; Hong Li
Journal:  Commun Biol       Date:  2022-03-29

8.  Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase.

Authors:  Jinzhong Lin; Mingxia Feng; Heping Zhang; Qunxin She
Journal:  Cell Discov       Date:  2020-05-12       Impact factor: 10.849

9.  Targeted RNA Knockdown by a Type III CRISPR-Cas Complex in Zebrafish.

Authors:  Thomas Fricke; Dalia Smalakyte; Maciej Lapinski; Abhishek Pateria; Charles Weige; Michal Pastor; Agnieszka Kolano; Cecilia Winata; Virginijus Siksnys; Gintautas Tamulaitis; Matthias Bochtler
Journal:  CRISPR J       Date:  2020-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.